Skip to main content
Equibles

LEVEL FOUR ADVISORY SERVICES, LLC

Position in GMAB — Genmab A/S

CIK 1696715 DALLAS, TX
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$1,593,260
+$63,333 QoQ
Shares Held
58,000
+1.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#74
of 292 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LEVEL FOUR ADVISORY SERVICES, LLC holds $9,160,165 across 9 Biotechnology names. GMAB ranks #2 (17.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 10,034 $4,984,188
2 GMAB
Genmab A/S
This page 		58,000 $1,593,260
3 ARGX
Argenx SE
 1,148 $1,065,079
4 JAZZ
Jazz Pharmaceuticals plc
 3,490 $840,985
5 TVTX
Travere Therapeutics, Inc.
 5,506 $312,795
6 REGN
Regeneron Pharmaceuticals, Inc.
 396 $246,921
7 MNKD
Mannkind Corp
 21,338 $90,899
8 OCGN
Ocugen, Inc.
 17,000 $26,010

All Filings in GMAB

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,593,260 58,000
2026-03-31 $1,529,927 57,023
2025-12-31 $1,879,631 61,027
2025-09-30 $2,065,409 67,343
2025-06-30 $1,341,350 64,925
2025-03-31 $1,018,884 52,037
2024-12-31 $346,859 16,620
2024-09-30 $1,030,981 42,288
2024-06-30 $306,887 12,212
2024-03-31 $207,605 6,941
2023-12-31 $221,001 6,941
2023-09-30 $323,849 9,182
2023-06-30 $368,126 9,685
2023-03-31 $325,944 8,632
2022-12-31 $279,241 6,589
2022-09-30 $306,584 9,542
2022-06-30 $310,929 9,570
2022-03-31 $399,282 11,036
2021-09-30 $375,601 8,595